These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 6273528
1. Interactions of d-tubocurarine with the nicotinic acetylcholine receptor/channel molecule. Shaker N, Eldefrawi AT, Aguayo LG, Warnick JE, Albuquerque EX, Eldefrawi ME. J Pharmacol Exp Ther; 1982 Jan; 220(1):172-7. PubMed ID: 6273528 [Abstract] [Full Text] [Related]
2. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies. Ikeda SR, Aronstam RS, Daly JW, Aracava Y, Albuquerque EX. Mol Pharmacol; 1984 Sep; 26(2):293-303. PubMed ID: 6090884 [Abstract] [Full Text] [Related]
3. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. Varanda WA, Aracava Y, Sherby SM, VanMeter WG, Eldefrawi ME, Albuquerque EX. Mol Pharmacol; 1985 Aug; 28(2):128-37. PubMed ID: 2410768 [Abstract] [Full Text] [Related]
4. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane. Warnick JE, Maleque MA, Bakry N, Eldefrawi AT, Albuquerque EX. Mol Pharmacol; 1982 Jul; 22(1):82-93. PubMed ID: 6126806 [Abstract] [Full Text] [Related]
5. Allosteric inhibition of nicotinic acetylcholine receptors of vertebrates and insects by philanthotoxin. Rozental R, Scoble GT, Albuquerque EX, Idriss M, Sherby S, Sattelle DB, Nakanishi K, Konno K, Eldefrawi AT, Eldefrawi ME. J Pharmacol Exp Ther; 1989 Apr; 249(1):123-30. PubMed ID: 2468760 [Abstract] [Full Text] [Related]
6. Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes. Spivak CE, Maleque MA, Oliveira AC, Masukawa LM, Tokuyama T, Daly JW, Albuquerque EX. Mol Pharmacol; 1982 Mar; 21(2):351-61. PubMed ID: 6285171 [Abstract] [Full Text] [Related]
7. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction. Maleque MA, Souccar C, Cohen JB, Albuquerque EX. Mol Pharmacol; 1982 Nov; 22(3):636-47. PubMed ID: 6296656 [Abstract] [Full Text] [Related]
8. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization. Souccar C, Varanda WA, Aronstam RS, Daly JW, Albuquerque EX. Mol Pharmacol; 1984 May; 25(3):395-400. PubMed ID: 6328265 [Abstract] [Full Text] [Related]
9. The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. Ramoa AS, Alkondon M, Aracava Y, Irons J, Lunt GG, Deshpande SS, Wonnacott S, Aronstam RS, Albuquerque EX. J Pharmacol Exp Ther; 1990 Jul; 254(1):71-82. PubMed ID: 1694895 [Abstract] [Full Text] [Related]
11. Molecular effects of dimethylanatoxin on the peripheral nicotinic acetylcholine receptor. Costa AC, Swanson KL, Aracava Y, Aronstam RS, Albuquerque EX. J Pharmacol Exp Ther; 1990 Feb; 252(2):507-16. PubMed ID: 1690291 [Abstract] [Full Text] [Related]
12. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties. Pascuzzo GJ, Akaike A, Maleque MA, Shaw KP, Aronstam RS, Rickett DL, Albuquerque EX. Mol Pharmacol; 1984 Jan; 25(1):92-101. PubMed ID: 6323955 [Abstract] [Full Text] [Related]
13. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. I. Blockade of the ionic channel. Souccar C, Varanda WA, Daly JW, Albuquerque EX. Mol Pharmacol; 1984 May; 25(3):384-94. PubMed ID: 6328264 [Abstract] [Full Text] [Related]
14. Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a. Swanson KL, Allen CN, Aronstam RS, Rapoport H, Albuquerque EX. Mol Pharmacol; 1986 Mar; 29(3):250-7. PubMed ID: 2419745 [Abstract] [Full Text] [Related]
15. Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites. Swanson KL, Aronstam RS, Wonnacott S, Rapoport H, Albuquerque EX. J Pharmacol Exp Ther; 1991 Oct; 259(1):377-86. PubMed ID: 1920124 [Abstract] [Full Text] [Related]
16. Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor. Albuquerque EX, Tsai MC, Aronstam RS, Eldefrawi AT, Eldefrawi ME. Mol Pharmacol; 1980 Sep; 18(2):167-78. PubMed ID: 6252436 [No Abstract] [Full Text] [Related]
17. [3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor. Eldefrawi ME, Eldefrawi AT, Aronstam RS, Maleque MA, Warnick JE, Albuquerque EX. Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7458-62. PubMed ID: 6261260 [Abstract] [Full Text] [Related]
18. Interaction of narcotic antagonist naltrexone with nicotinic acetylcholine receptor. Oliveira L, Madsen BW, Kapai N, Sherby SM, Swanson KL, Eldefrawi ME, Albuquerque EX. Eur J Pharmacol; 1987 Aug 21; 140(3):331-42. PubMed ID: 3653249 [Abstract] [Full Text] [Related]
19. The nonoxime bispyridinium compound SAD-128 alters the kinetic properties of the nicotinic acetylcholine receptor ion channel: a possible mechanism for antidotal effects. Alkondon M, Albuquerque EX. J Pharmacol Exp Ther; 1989 Sep 21; 250(3):842-52. PubMed ID: 2476549 [Abstract] [Full Text] [Related]
20. Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane. Albuquerque EX, Tsai MC, Aronstam RS, Witkop B, Eldefrawi AT, Eldefrawi ME. Proc Natl Acad Sci U S A; 1980 Feb 21; 77(2):1224-8. PubMed ID: 6928673 [Abstract] [Full Text] [Related] Page: [Next] [New Search]